Darren Sherman - Sep 4, 2024 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
President and Chief Operating Officer, Director
Signature
/s/ Andrew Taylor, Attorney-in-Fact
Stock symbol
OBIO
Transactions as of
Sep 4, 2024
Transactions value $
-$120,955
Form type
4
Date filed
9/6/2024, 07:31 PM
Previous filing
May 10, 2024
Next filing
Sep 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock, par value $0.0001 per share ("Common Stock") Sale -$41.7K -6.84K -0.85% $6.10 793K Sep 4, 2024 Direct F1, F2
transaction OBIO Common Stock Sale -$40.7K -6.96K -0.88% $5.85 786K Sep 5, 2024 Direct F1, F3
transaction OBIO Common Stock Sale -$38.5K -6.82K -0.87% $5.65 779K Sep 6, 2024 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
F2 The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.19, inclusive. The reporting person hereby undertakes to provide upon request to the staff of the Securities and Exchange Commission (the "SEC"), the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.61 to $6.14, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.50 to $5.94, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

President and Chief Operating Officer